换一批
换一批Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study.
作者：
Yuma,Nato [1]
;
Kana,Miyazaki [2]
;
Dai,Maruyama [3]
;
Hiroyuki,Takahashi [4]
;
Kazutaka,Sunami [5]
;
Satsuki,Murakami [6]
;
Eiju,Negoro [7]
;
Yuri,Miyazawa [8]
;
Ilseung,Choi [9]
;
Takahiro,Okada [10]
;
Nobuyuki,Takayama [11]
;
Naoto,Tomita [12]
;
Shuji,Momose [13]
;
Yuto,Kaneda [14]
;
Masahiro,Yoshida [15]
;
Hiroshi,Gomyo [16]
;
Kohtaro,Toyama [17]
;
Momoko,Nishikori [18]
;
Akio,Saito [19]
;
Junji,Hiraga [20]
;
Taro,Masunari [21]
;
Naoki,Takahashi [22]
;
Junya,Makiyama [23]
;
Tomotaka,Suzuki [24]
;
Hiroko,Tsunemine [25]
;
Jun,Takizawa [26]
;
Takeharu,Kato [27]
;
Yasufumi,Masaki [28]
;
Noriko,Fukuhara [29]
;
Masataka,Okamoto [30]
;
Isao,Tawara [2]
;
Naoko,Asano [31]
;
Koichi,Ohshima [32]
;
Koji,Izutsu [33]
;
Koji,Kato [34]
;
Ritsuro,Suzuki [10]
;
Motoko,Yamaguchi [35]
作者单位：
Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan.;Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
[1]
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
[2]
Department of Hematology Oncology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.
[3]
Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
[4]
Department of Hematology, NHO Okayama Medical Center, Okayama, Japan.
[5]
Department of Hematology, Aichi Medical University, Nagakute, Japan.
[6]
Department of Hematology and Oncology, University of Fukui, Fukui, Japan.
[7]
Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
[8]
Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan.
[9]
Department of Hematology and Oncology, Shimane University School of Medicine, Izumo, Japan.
[10]
Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Japan.
[11]
Department of Hematology and Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
[12]
Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
[13]
Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
[14]
Department of Hematology, Osaka City General Hospital, Osaka, Japan.
[15]
Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
[16]
Department of Hematology, Fujioka General Hospital, Gunma, Japan.
[17]
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
[18]
Department of Hematology, NHO Shibukawa Medical Center, Gunma, Japan.
[19]
Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.
[20]
Department of Hematology/Infectious Diseases, Chugoku Central Hospital, Fukuyama, Japan.
[21]
Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan.
[22]
Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
[23]
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
[24]
Department of Hematology, Shinko Hospital, Kobe, Japan.
[25]
Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan.
[26]
Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
[27]
Department of Hematology and Immunology, Kanazawa Medical University, Kahoku-gun, Japan.
[28]
Department of Hematology, Tohoku University Hospital, Sendai, Japan.
[29]
Department of Hematology and Oncology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
[30]
Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan.
[31]
Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
[32]
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
[33]
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
[34]
Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan.
[35]
主题词
人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);成年人(Adult);回顾性研究(Retrospective Studies);老年人, 80以上(Aged, 80 and over);长春新碱(Vincristine);多柔比星(Doxorubicin);环磷酰胺(Cyclophosphamide);青年人(Young Adult);治疗结果(Treatment Outcome);存活率(Survival Rate);预后(Prognosis);甲氨蝶呤(Methotrexate);依托泊甙(Etoposide)
DOI
10.1002/hon.70047
PMID
39937961
发布时间
2025-02-12
- 浏览0
Hematological oncology
Hematological oncology
e70047页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
